Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 3

NF-κΒ and SOD expression in preeclamptic placentas

Pages
783–788
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Familial presence of preeclampsia could predispose to altered expression in SOD and NF-κΒ.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Preeclampsia is a leading cause of maternal death in the developing world.
📊
Key Findings & Data:The 2 ΔΔct analysis method was used to measure the difference in the relative expression of the target genes in each group of patients.
💡
Conclusion & Impact:Conclusion: Familial presence of preeclampsia could predispose to altered expression in SOD and NF-κΒ.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Preeclampsia is a leading cause of maternal death in the developing world. Our aim was to quantify and compare messenger (mRNA) expression of nuclear factor-kappa beta (NF-κΒ) and superoxide dismutase (SOD) in control patients with preeclampsia and without preeclampsia with or without familial hereditary background. Materials and methods: Four groups of patients were formed depending on the presence or absence of preeclampsia and presence or absence of familial history for preeclampsia. NF-κΒ and SOD were measured in human placentas by real-time quantitative polymerase chain reaction. The 2 ΔΔct analysis method was used to measure the difference in the relative expression of the target genes in each group of patients. Results: In NF-κΒ expression, there was an increase of 23.35% in the group of women with preeclampsia versus women with preeclampsia without familial history. Regarding SOD, there was a reduction of about 33.33% in the expression in women with preeclampsia with familial history versus women with preeclampsia without familial history. Conclusion: Familial presence of preeclampsia could predispose to altered expression in SOD and NF-κΒ.

🔖

Cite This Article

CARMONA, A. S., ZERÓN, H. M. (2022). NF-κΒ and SOD expression in preeclamptic placentas. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 3, 783–788. https://ajindex.com/articles/610727

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137. 2. van Dijk MG, Díaz Olavarrieta C, Zuñiga PU, Gordillo RL, Gutiérrez ME, García SG. Use of magnesium sulfate for treatment of pre-eclampsia and eclampsia in Mexico. Int J Gynaecol Obs 2013; 121: 110-114
  2. Romero-Arauz JF1, Morales-Borrego E, García-Espinosa M, Peralta-Pedrero ML. Clinical guideline. Preeclampsiaeclampsia. Rev Med Inst Mex Seguro Soc 2012; 50: 569-579 (in Spanish with English abstract)
  3. Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW. A sister’s risk: family history as a predictor of preeclampsia. Am J Obs Gynecol 2005; 193: 965-972
  4. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344: 867- 872
  5. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008; 313: 37-44
  6. Vanderlelie J, Gude N, Perkins AV. Antioxidant gene expression in preeclamptic placentae: a preliminary investigation. Placenta 2008; 29: 519-522
  7. Kurlak LO, Green A, Loughna P, Broughton Pipkin F. Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease. Front Physiol 2014; 5: 310
  8. Tortladze M, Kintraia N, Parkauli M, Sanikidze T. Blood antioxidant enzyme activity during physiological and preeclampsia syndrome complicated pregnancy. Georg Med News 2013; 215: 12-16 (in Russian with English abstract)
  9. Dennery PA. Effects of oxidative stress on embryonic development. Birth Defects Res C Embryo Today 2007; 81: 155-162
  10. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 981-990
  11. Siomek A. NF-κB signaling pathway and free radical impact. Acta Biochim Pol 2012; 59: 323-331
  12. Winyard PG, Blake DR. Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 1997; 38: 403-421
  13. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99: 159-167
  14. Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. Pathogenesis of preeclampsia: the genetic component. J Pregnancy 2012: 2012: 632732
  15. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing pre-eclampsia a